P Griffin

Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy. CNA2001 Investigative Group.

C Stone, P. Harrigan, B. Larder, 2000, The Journal of infectious diseases.